Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
2.575
-0.185 (-6.70%)
Jan 21, 2025, 4:00 PM EST - Market closed
Intensity Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jan '25 Jan 21, 2025 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 39 | 117 | - | - | - | - |
| Enterprise Value | 36 | 102 | - | - | - | - |
| Last Close Price | 2.58 | 8.57 | - | - | - | - |
| PB Ratio | 12.85 | 8.93 | - | - | - | - |
| P/TBV Ratio | 18.93 | 8.93 | - | - | - | - |
| Debt / Equity Ratio | 0.05 | 0.01 | -0.88 | 1.78 | 0.06 | 0.03 |
| Quick Ratio | 1.20 | 3.73 | 0.19 | 1.23 | 6.96 | 7.46 |
| Current Ratio | 1.63 | 3.91 | 0.21 | 1.27 | 7.04 | 7.67 |
| Return on Equity (ROE) | -173.99% | -261.36% | - | -161.84% | -75.07% | - |
| Return on Assets (ROA) | -94.96% | -54.58% | -135.34% | -65.19% | -40.77% | - |
| Return on Capital (ROIC) | -110.15% | -81.79% | -309.17% | -79.52% | -46.24% | - |
| Earnings Yield | -41.81% | -8.97% | - | - | - | - |
| FCF Yield | -34.71% | -6.13% | - | - | - | - |
| Buyback Yield / Dilution | -128.09% | -152.67% | - | -0.02% | -0.19% | - |
| Total Shareholder Return | -128.09% | -152.67% | - | -0.02% | -0.19% | - |
Source: S&P Capital IQ. Standard template.
Financial Sources.